Moderna's experimental coronavirus vaccine gets FDA's 'fast track' status

(Reuters) – Moderna Inc said on Tuesday its experimental coronavirus vaccine had gained the U.S. Food and Drug Administration’s “fast track” designation.

The agency’s fast track status is designed to expedite the review of treatments and vaccines meant for serious conditions.

Reporting by Manas Mishra in Bengaluru; Editing by Amy Caren Daniel

Our Standards:The Thomson Reuters Trust Principles.

source: reuters.com

🕐 Top News in the Last Hour By Importance Score

#	Title	📊 i-Score
1	New VR Program Gives Domestic Abusers a Taste of Their Own Medicine	🔴 75 / 100
2	Car tax hike for petrol, diesel and electric vehicles hits owners today	🔴 65 / 100
3	The King of Kings review: Oscar Isaac’s Jesus leads A-list cast in heartwarming animation	🔴 65 / 100
4	Man plans to use World War II bomb found in his garden as beer cooler	🔵 55 / 100
5	Nintendo Switch 2 Hardware Detailed; 120 FPS, HDR, And More	🔵 55 / 100
6	Moment parachutist left dangling on stadium roof	🔵 35 / 100
7	Mark Anderson on Asking His Kids to Date Again: ‘Tough Thing to Approach’	🔵 35 / 100
8	Pompeii breakthrough as two incredible 'life-sized' sculptures discovered in ancient tomb	🔵 35 / 100
9	Injured Russo replaced by England Under-19s striker Michelle Agyemang	🔵 25 / 100
10	Man Utd player ratings vs Man City: Four stars stand out as Red Devils earn a point	🔵 20 / 100

View More Top News ➡️